NCT06075030View on ClinicalTrials.gov

A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

May 31, 2026

Conditions
Chemotherapy Induced Anemia
Interventions
DRUG

AND017

Oral administration of AND017 capsules three times per week

Sponsors
All Listed Sponsors
lead

Kind Pharmaceuticals LLC

INDUSTRY